Erratum: Corrigenda (The Journal of Allergy and Clinical Immunology (2018) 142(5) (1618–1627.e9), (S0091674918305165), (10.1016/j.jaci.2018.04.001));Thirdhand smoke component can exacerbate a mouse asthma model through mast cells

Journal of Allergy and Clinical Immunology

Volumn 142, Issue 5, 2018, Pages 1618-1627.e9

  Yu, Mang ^a   Mukai, Kaori ^a   Tsai, Mindy ^a   Galli, Stephen J ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

4 (methylnitrosamino) 1 (3 pyridyl) 1 butanone; cockroach allergen; mast cells; Thirdhand smoke; 7 nicotinic acetylcholine receptor

Indexed keywords

4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4 CHLORO N (3 QUINUCLIDINYL)BENZAMIDE; ANTIGEN; BUNGAROTOXIN RECEPTOR; COCKROACH ANTIGEN; UNCLASSIFIED DRUG; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; ALLERGEN; CYTOKINE; NITROSAMINE; OVALBUMIN;

AIRWAY REMODELING; ALLERGIC AIRWAY INFLAMMATION; AMBIENT AIR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTHMA; BRONCHUS HYPERREACTIVITY; CONTROLLED STUDY; DISEASE EXACERBATION; DUST; ENVIRONMENTAL EXPOSURE; FEMALE; HOST; INFLAMMATORY INFILTRATE; MAST CELL; METHACHOLINE-INDUCED BRONCHOCONSTRICTION; MOUSE; MOUSE MODEL; NONHUMAN; PASSIVE SMOKING; PRIORITY JOURNAL; THIRDHAND SMOKE; WILD TYPE MOUSE; ADVERSE EVENT; ANIMAL; C57BL MOUSE; COCKROACH; DISEASE MODEL; DRUG EFFECT; GENETICS; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; LUNG; SKIN; SMOKE; TRANSGENIC MOUSE;

ADMINISTRATION, INTRANASAL; ALLERGENS; ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; ASTHMA; COCKROACHES; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; LUNG; MAST CELLS; MICE, INBRED C57BL; MICE, TRANSGENIC; NITROSAMINES; OVALBUMIN; SKIN; SMOKE; TOBACCO SMOKE POLLUTION;

EID: 85046685820     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2021.01.019     Document Type: Erratum

References (72)

1. Winickoff, J.P., Friebely, J., Tanski, S.E., Sherrod, C., Matt, G.E., Hovell, M.F., et al. Beliefs about the health effects of “thirdhand” smoke and home smoking bans. Pediatrics 123 (2009), e74–e79.
2. Pirkle, J.L., Flegal, K.M., Bernert, J.T., Brody, D.J., Etzel, R.A., Maurer, K.R., Exposure of the US population to environmental tobacco smoke: the Third National Health and Nutrition Examination Survey, 1988 to 1991. JAMA 275 (1996), 1233–1240.
3. Petrick, L.M., Svidovsky, A., Dubowski, Y., Thirdhand smoke: heterogeneous oxidation of nicotine and secondary aerosol formation in the indoor environment. Environ Sci Technol 45 (2011), 328–333.
4. Quintana, P.J., Matt, G.E., Chatfield, D., Zakarian, J.M., Fortmann, A.L., Hoh, E., Wipe sampling for nicotine as a marker of thirdhand tobacco smoke contamination on surfaces in homes, cars, and hotels. Nicotine Tob Res 15 (2013), 1555–1563.
5. Bentayeb, M., Simoni, M., Norback, D., Baldacci, S., Maio, S., Viegi, G., et al. Indoor air pollution and respiratory health in the elderly. J Environ Sci Health A Tox Hazard Subst Environ Eng 48 (2013), 1783–1789.
6. Sleiman, M., Gundel, L.A., Pankow, J.F., Jacob, P. 3rd, Singer, B.C., Destaillats, H., Formation of carcinogens indoors by surface-mediated reactions of nicotine with nitrous acid, leading to potential thirdhand smoke hazards. Proc Natl Acad Sci U S A 107 (2010), 6576–6581.
7. Kuschner, W.G., Reddy, S., Mehrotra, N., Paintal, H.S., Electronic cigarettes and thirdhand tobacco smoke: two emerging health care challenges for the primary care provider. Int J Gen Med 4 (2011), 115–120.
8. Kassem, N.O., Daffa, R.M., Liles, S., Jackson, S.R., Kassem, N.O., Younis, M.A., et al. Children's exposure to secondhand and thirdhand smoke carcinogens and toxicants in homes of hookah smokers. Nicotine Tob Res 16 (2014), 961–975.
9. Martins-Green, M., Adhami, N., Frankos, M., Valdez, M., Goodwin, B., Lyubovitsky, J., et al. Cigarette smoke toxins deposited on surfaces: implications for human health. PLoS One, 9, 2014, e86391.
10. Karim, Z.A., Alshbool, F.Z., Vemana, H.P., Adhami, N., Dhall, S., Espinosa, E.V., et al. Third-hand smoke: impact on hemostasis and thrombogenesis. J Cardiovasc Pharmacol 66 (2015), 177–182.
11. Adhami, N., Starck, S.R., Flores, C., Martins Green, M., A health threat to bystanders living in the homes of smokers: how smoke toxins deposited on surfaces can cause insulin resistance. PLoS One, 11, 2016, e0149510.
12. Dhall, S., Alamat, R., Castro, A., Sarker, A.H., Mao, J.H., Chan, A., et al. Tobacco toxins deposited on surfaces (third hand smoke) impair wound healing. Clin Sci 130 (2016), 1269–1284.
13. Schuller, H.M., Nitrosamines as nicotinic receptor ligands. Life Sci 80 (2007), 2274–2280.
14. Fujii, T., Tajima, S., Yamada, S., Watanabe, Y., Sato, K.Z., Matsui, M., et al. Constitutive expression of mRNA for the same choline acetyltransferase as that in the nervous system, an acetylcholine-synthesizing enzyme, in human leukemic T-cell lines. Neurosci Lett 259 (1999), 71–74.
15. Sato, K.Z., Fujii, T., Watanabe, Y., Yamada, S., Ando, T., Kazuko, F., et al. Diversity of mRNA expression for muscarinic acetylcholine receptor subtypes and neuronal nicotinic acetylcholine receptor subunits in human mononuclear leukocytes and leukemic cell lines. Neurosci Lett 266 (1999), 17–20.
16. Kawashima, K., Fujii, T., Expression of non-neuronal acetylcholine in lymphocytes and its contribution to the regulation of immune function. Front Biosci 9 (2004), 2063–2085.
17. Skok, M., Grailhe, R., Agenes, F., Changeux, J.P., The role of nicotinic acetylcholine receptors in lymphocyte development. J Neuroimmunol 171 (2006), 86–98.
18. Wang, D.W., Zhou, R.B., Yao, Y.M., Zhu, X.M., Yin, Y.M., Zhao, G.J., et al. Stimulation of alpha7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro. J Pharmacol Exp Ther 335 (2010), 553–561.
19. Aicher, A., Heeschen, C., Mohaupt, M., Cooke, J.P., Zeiher, A.M., Dimmeler, S., Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions. Circulation 107 (2003), 604–611.
20. Guinet, E., Yoshida, K., Nouri-Shirazi, M., Nicotinic environment affects the differentiation and functional maturation of monocytes derived dendritic cells (DCs). Immunol Lett 95 (2004), 45–55.
21. Wang, H., Yu, M., Ochani, M., Amella, C.A., Tanovic, M., Susarla, S., et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421 (2003), 384–388.
22. Blanchet, M.R., Langlois, A., Israel-Assayag, E., Beaulieu, M.J., Ferland, C., Laviolette, M., et al. Modulation of eosinophil activation in vitro by a nicotinic receptor agonist. J Leukoc Biol 81 (2007), 1245–1251.
23. Sudheer, P.S., Hall, J.E., Donev, R., Read, G., Rowbottom, A., Williams, P.E., Nicotinic acetylcholine receptors on basophils and mast cells. Anaesthesia 61 (2006), 1170–1174.
24. Kageyama-Yahara, N., Suehiro, Y., Yamamoto, T., Kadowaki, M., IgE-induced degranulation of mucosal mast cells is negatively regulated via nicotinic acetylcholine receptors. Biochem Biophys Res Commun 377 (2008), 321–325.
25. Mishra, N.C., Rir-sima-ah, J., Boyd, R.T., Singh, S.P., Gundavarapu, S., Langley, R.J., Razani-Boroujerdi, S., et al. Nicotine inhibits Fc epsilon RI-induced cysteinyl leukotrienes and cytokine production without affecting mast cell degranulation through alpha 7/alpha 9/alpha 10-nicotinic receptors. J Immunol 185 (2010), 588–596.
26. Radosa, J., Dyck, W., Goerdt, S., Kurzen, H., The cholinergic system in guttate psoriasis with special reference to mast cells. Exp Dermatol 20 (2011), 677–679.
27. Busse, W.W., Lemanske, R.F. Jr., Asthma. N Engl J Med 344 (2001), 350–362.
28. Umetsu, D.T., McIntire, J.J., Akbari, O., Macaubas, C., DeKruyff, R.H., Asthma: an epidemic of dysregulated immunity. Nat Immunol 3 (2002), 715–720.
29. Kitamura, Y., Heterogeneity of mast cells and phenotypic change between subpopulations. Annu Rev Immunol 7 (1989), 59–76.
30. Chen, C.-C., Grimbaldeston, M.A., Tsai, M., Weissman, I.L., Galli, S.J., Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci U S A 102 (2005), 11408–11413.
31. Metcalfe, D.D., Baram, D., Mekori, Y.A., Mast cells. Physiol Rev 77 (1997), 1033–1079.
32. Bradding, P., Walls, A.F., Holgate, S.T., The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol 117 (2006), 1277–1284.
33. Williams, C.M., Galli, S.J., The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 105 (2000), 847–859.
34. Gurish, M.F., Austen, K.F., The diverse roles of mast cells. J Exp Med 194 (2001), F1–F5.
35. Kawakami, T., Galli, S.J., Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2 (2002), 773–786.
36. Boyce, J.A., Mast cells: beyond IgE. J Allergy Clin Immunol 111 (2003), 24–33.
37. Galli, S.J., Nakae, S., Tsai, M., Mast cells in the development of adaptive immune responses. Nat Immunol 6 (2005), 135–142.
38. Rivera, J., Fierro, N.A., Olivera, A., Suzuki, R., New insights on mast cell activation via the high affinity receptor for IgE. Adv Immunol 98 (2008), 85–120.
39. Yamamoto, T., Kodama, T., Lee, J., Utsunomiya, N., Hayashi, S., Sakamoto, H., et al. Anti-allergic role of cholinergic neuronal pathway via alpha7 nicotinic ACh receptors on mucosal mast cells in a murine food allergy model. PLoS One, 9, 2014, e85888.
40. de Haan, J.J., Hadfoune, M., Lubbers, T., Hodin, C., Lenaerts, K., Ito, A., et al. Lipid-rich enteral nutrition regulates mucosal mast cell activation via the vagal anti-inflammatory reflex. Am J Physiol Gastrointest Liver Physiol 305 (2013), G383–G391.
41. Mishra, N.C., Rir-Sima-Ah, J., Langley, R.J., Singh, S.P., Pena-Philippides, J.C., Koga, T., et al. Nicotine primarily suppresses lung Th2 but not goblet cell and muscle cell responses to allergens. J Immunol 180 (2008), 7655–7663.
42. Aung, G., Niyonsaba, F., Ushio, H., Kajiwara, N., Saito, H., Ikeda, S., et al. Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines. Immunology 132 (2011), 527–539.
43. de la Riva-Velasco, E., Krishnan, S., Dozor, A.J., Relationship between exhaled nitric oxide and exposure to low-level environmental tobacco smoke in children with asthma on inhaled corticosteroids. J Asthma 49 (2012), 673–678.
44. Rosenstreich, D.L., Eggleston, P., Kattan, M., Baker, D., Slavin, R.G., Gergen, P., et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med 336 (1997), 1356–1363.
45. Gergen, P.J., Mortimer, K.M., Eggleston, P.A., Rosenstreich, D., Mitchell, H., Ownby, D., et al. Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes. J Allergy Clin Immunol 103 (1999), 501–506.
46. Matsui, E.C., Environmental exposures and asthma morbidity in children living in urban neighborhoods. Allergy 69 (2014), 553–558.
47. Piliponsky, A.M., Chen, C.C., Grimbaldeston, M.A., Burns-Guydish, S.M., Hardy, J., Kalesnikoff, J., et al. Mast cell-derived TNF can exacerbate mortality during severe bacterial infections in C57BL/6-KitW-sh/W-sh mice. Am J Pathol 176 (2010), 926–938.
48. Lilla, J.N., Chen, C.C., Mukai, K., Benbarak, M.J., Franco, C.B., Kalesnikoff, J., et al. Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl/fl mice. Blood 118 (2011), 6930–6938.
49. Yu, M., Eckart, M.R., Morgan, A.A., Mukai, K., Butte, A.J., Tsai, M., et al. Identification of an IFN-gamma/mast cell axis in a mouse model of chronic asthma. J Clin Invest 121 (2011), 3133–3143.
50. Yu, M., Tsai, M., Tam, S.Y., Jones, C., Zehnder, J., Galli, S.J., Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 116 (2006), 1633–1641.
51. de Jonge, W.J., Ulloa, L., The alpha7 nicotinic acetylcholine receptor as a pharmacological target for inflammation. Br J Pharmacol 151 (2007), 915–929.
52. Kawashima, K., Fujii, T., Basic and clinical aspects of non-neuronal acetylcholine: overview of non-neuronal cholinergic systems and their biological significance. J Pharmacol Sci 106 (2008), 167–173.
53. Tracey, K.J., Physiology and immunology of the cholinergic antiinflammatory pathway. J Clin Invest 117 (2007), 289–296.
54. Pavlov, V.A., Cholinergic modulation of inflammation. Int J Clin Exp Med 1 (2008), 203–212.
55. Blanchet, M.R., Israel-Assayag, E., Cormier, Y., Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitro. Am J Respir Crit Care Med 169 (2004), 903–909.
56. Blanchet, M.R., Israel-Assayag, E., Cormier, Y., Modulation of airway inflammation and resistance in mice by a nicotinic receptor agonist. Eur Respir J 26 (2005), 21–27.
57. Gilliland, F.D., Li, Y.F., Peters, J.M., Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 163 (2001), 429–436.
58. Akinbami, L.J., Kit, B.K., Simon, A.E., Impact of environmental tobacco smoke on children with asthma, United States, 2003-2010. Acad Pediatr 13 (2013), 508–516.
59. Kit, B.K., Simon, A.E., Brody, D.J., Akinbami, L.J., US prevalence and trends in tobacco smoke exposure among children and adolescents with asthma. Pediatrics 131 (2013), 407–414.
60. Burke, H., Leonardi-Bee, J., Hashim, A., Pine-Abata, H., Chen, Y., Cook, D.G., et al. Prenatal and passive smoke exposure and incidence of asthma and wheeze: systematic review and meta-analysis. Pediatrics 129 (2012), 735–744.
61. Stapleton, M., Howard-Thompson, A., George, C., Hoover, R.M., Self, T.H., Smoking and asthma. J Am Board Fam Med 24 (2011), 313–322.
62. Menzies, D., The case for a worldwide ban on smoking in public places. Curr Opin Pulm Med 17 (2011), 116–122.
63. Ahluwalia, S.K., Matsui, E.C., The indoor environment and its effects on childhood asthma. Curr Opin Allergy Clin Immunol 11 (2011), 137–143.
64. Brunnemann, K.D., Prokopczyk, B., Djordjevic, M.V., Hoffmann, D., Formation and analysis of tobacco-specific N-nitrosamines. Crit Rev Toxicol 26 (1996), 121–137.
65. Pierce, R.A., Nguyen, N.M., Prenatal nicotine exposure and abnormal lung function. Am J Respir Cell Mol Biol 26 (2002), 10–13.
66. Rehan, V.K., Asotra, K., Torday, J.S., The effects of smoking on the developing lung: insights from a biologic model for lung development, homeostasis, and repair. Lung 187 (2009), 281–289.
67. Dreyfuss, J.H., Thirdhand smoke identified as potent, enduring carcinogen. CA Cancer J Clin 60 (2010), 203–204.
68. Sly, P.D., The early origins of asthma: who is really at risk?. Curr Opin Allergy Clin Immunol 11 (2011), 24–28.
69. Yu, M., Tsai, M., Tam, S.Y., Jones, C., Zehnder, J., Galli, S.J., Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 116 (2006), 1633–1641.
70. Yu, M., Eckart, M.R., Morgan, A.A., Mukai, K., Butte, A.J., Tsai, M., Galli, S.J., Identification of an IFN-γ/mast cell axis in a mouse model of chronic asthma. J Clin Invest 121 (2011), 3133–3143.
71. Martins-Green, M., Adhami, N., Frankos, M., Valdez, M., Goodwin, B., Lyubovitsky, J., et al. Cigarette smoke toxins deposited on surfaces: implications for human health. PLoS One, 9, 2014, e86391.
72. Bernert, J.T., Pirkle, J.L., Xia, Y., Jain, R.B., Ashley, D.L., Sampson, E.J., Urine concentrations of a tobacco-specific nitrosamine carcinogen in the U.S. population from secondhand smoke exposure. Cancer Epidemiol Biomarkers Prev 19 (2010), 2969–2977.